Bumetanide

Bumetanide · BUMETANIDE .25 mg/mL · Injection · Intramuscular; Intravenous · Qilu Pharmaceutical Co., Ltd.

NDC 67184-0594-02 · 10 VIAL in 1 CARTON / 10 mL in 1 VIAL · ANDA · View full market →

The short version

13 companies supply this market — deep enough that no single failure threatens the supply. It is in shortage right now.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Qilu Pharmaceutical (Hainan) Co., Ltd.China
analysis · manufacture

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

Part D specialty tier
Costs ≥ $950/fill · avg $32.71 per prescription
Biologic (BLA)
Injectable / infused
Orphan-drug exclusivity
REMS program

Regulatory

Application: ANDA219116
TE code: AP
Approval date: Sep 19, 2024
Patents / exclusivity: None on file

Shortage history

In shortage now — Bumetanide, Injection, .25 mg/1 mL (NDC 65219-570-04)Jan 31, 2018
month 104 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bumetanide, Injection, .25 mg/1 mL (NDC 65219-572-10)Jan 31, 2018
month 104 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bumetanide, Injection, 0.25 mg/1 mL (NDC 72205-101-07)Dec 13, 2017
month 105 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bumetanide, Injection, 0.25 mg/1 mL (NDC 72205-102-07)Dec 13, 2017
month 105 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bumetanide, Injection, 1 mg/4 mL (0.25 mg/mL) (NDC 83301-0080-2)Dec 13, 2017
month 105 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bumetanide, Injection, 2.5 mg/10 mL (0.25 mg/mL) (NDC 83301-0081-2)Dec 13, 2017
month 105 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Bumetanide (Injection)

Labeler	Strength	First seen	Last seen
Bryant Ranch Prepack	BUMETANIDE .25 mg/mL	Jul 15, 2026	Sep 3, 2026
Camber Pharmaceuticals, Inc.	BUMETANIDE .25 mg/mL	Jul 15, 2026	Sep 3, 2026
Cardinal Health 107, LLC	BUMETANIDE .25 mg/mL	Jul 15, 2026	Sep 3, 2026
Gland Pharma Limited	BUMETANIDE .25 mg/mL	Jul 15, 2026	Sep 3, 2026
Hikma Pharmaceuticals USA Inc.	BUMETANIDE .25 mg/mL	Jul 15, 2026	Sep 3, 2026
Mullan Pharmaceutical Inc.	BUMETANIDE .25 mg/mL	Jul 15, 2026	Sep 3, 2026
Novadoz Pharmaceuticals LLC	BUMETANIDE .25 mg/mL	Jul 15, 2026	Sep 3, 2026
Fresenius Kabi USA, LLC	BUMETANIDE .25 mg/mL	Jul 15, 2026	Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirst	BUMETANIDE .25 mg/mL	Jul 15, 2026	Sep 2, 2026
Lupin Pharmaceuticals, Inc.	BUMETANIDE .25 mg/mL	Jul 15, 2026	Sep 2, 2026
Civica, Inc.	BUMETANIDE .25 mg/mL	Jul 15, 2026	Aug 31, 2026
Glenmark Pharmaceuticals Inc., Usa	BUMETANIDE .25 mg/mL	Jul 15, 2026	Aug 31, 2026
Qilu Pharmaceutical Co., Ltd.	BUMETANIDE .25 mg/mL	Jul 15, 2026	Aug 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Bumetanide — NDC 67184-0594-02," retrieved September 3, 2026, https://drugdashboards.com/drug/67184059402.

Free to cite with attribution — see how the data is put together.